Evidence-based·Last reviewed May 30, 2026·How we grade evidence

CoQ10

SpecialtyUbiquinoneBest in the morningBest taken with food

Useful mainly for statin users with muscle complaints, and adults with heart failure as adjunctive support.

Quick decision guide

May help most

Statin users with muscle complaints, and adults with heart failure as adjunctive support

Common dosing range

100–300 mg/day with fat-containing meals

When to expect effects

Weeks (4–12 weeks for clinical endpoints)

Watch out for

May reduce warfarin effectiveness — monitor INR if combining

What is it

Coenzyme Q10 (CoQ10, also called ubiquinone in its oxidized form and ubiquinol in its reduced form) is a fat-soluble compound the body synthesizes endogenously. It is found in nearly every cell membrane, with the highest concentrations in heart, liver, and kidney tissue, where mitochondrial activity is highest.

Is it worth it for you?

Use this as a quick fit check, not a diagnosis.

Worth considering if

You are on a statin and experiencing muscle pain or weakness without another explanation
You have heart failure (NYHA class II–IV) using CoQ10 as an adjunct to standard care
You have frequent migraines and are exploring preventive adjuncts
You are older and have mitochondria-related fatigue — endogenous production declines with age

Probably skip if

You are on warfarin without INR monitoring capability
You are undergoing chemotherapy with anthracyclines without oncology coordination
You expect reversal of cardiovascular disease — it is an adjunct, not primary treatment
You are healthy and young with no statin use — no established benefit for general wellness

Evidence at a glance

heart failure (adjunctive support)

Good Evidence
Effect
Modest improvement in symptoms and quality of life; one large RCT (Q-SYMBIO) showed reduced cardiovascular events
Best fit
Adults with systolic heart failure (NYHA class II–IV) on standard medical therapy
Time
Months

migraine prevention

Good Evidence
Effect
Reduction in migraine frequency (days/month) in several RCTs
Best fit
Adults with frequent migraines (>2–4/month) seeking preventive adjuncts
Time
Months (typically 3 months before meaningful frequency reduction)

statin-induced myalgia

Limited Evidence
Effect
Mixed; some trials show muscle pain reduction, others show no benefit
Best fit
Statin users with documented muscle pain and no other explanation, with confirmed low plasma CoQ10
Time
Weeks

blood pressure (biomarker)

Limited Evidence
Effect
~3–5 mmHg systolic reduction in meta-analyses
Best fit
Adults with hypertension on antihypertensive therapy
Time
Weeks to months

Evidence for 4 uses

AI-assisted evidence assessment — talk to your doctor before relying on any single supplement.

heart failure (adjunctive support)

Disease adjunct
Good Evidence

The Q-SYMBIO trial (420 participants) found CoQ10 300 mg/day significantly reduced major adverse cardiovascular events and cardiovascular mortality compared to placebo in heart failure patients over 2 years. Smaller RCTs and meta-analyses support improvements in exercise tolerance and quality of life. CoQ10 is proposed to restore impaired mitochondrial energy production in failing myocardium. This is an adjunctive use; it does not replace standard heart failure pharmacotherapy.

Effect size
Modest improvement in symptoms and quality of life; one large RCT (Q-SYMBIO) showed reduced cardiovascular events
Time to effect
Months
Best fit
Adults with systolic heart failure (NYHA class II–IV) on standard medical therapy
Less likely
People with normal cardiac function — no evidence of benefit

Bottom line: Credible adjunctive option in heart failure — the Q-SYMBIO trial provides meaningful trial evidence, though larger confirmatory trials are needed.

migraine prevention

Supplement benefit
Good Evidence

Multiple small RCTs and a meta-analysis support CoQ10 (300600 mg/day) reducing migraine frequency by roughly 12 attacks per month vs. placebo. A subgroup of migraineurs may have impaired mitochondrial energy metabolism in cortical tissue, which CoQ10 is proposed to correct. Effect size is moderate; CoQ10 is generally well-tolerated, making it a reasonable preventive adjunct alongside lifestyle measures.

Effect size
Reduction in migraine frequency (days/month) in several RCTs
Time to effect
Months (typically 3 months before meaningful frequency reduction)
Best fit
Adults with frequent migraines (>2–4/month) seeking preventive adjuncts

Bottom line: A reasonable preventive option for frequent migraine, particularly for those seeking non-pharmacological adjuncts.

statin-induced myalgia

Disease adjunct
Limited Evidence

Statins inhibit HMG-CoA reductase upstream of CoQ10 biosynthesis, consistently reducing plasma CoQ10 levels. Whether this reduction causes statin myopathy remains debated. RCTs of CoQ10 for statin myalgia are mixedsome show reduction in muscle pain scores, others do not. Meta-analyses find inconsistent results. The intervention is low-risk in statin users and merits a supervised trial given the mechanistic rationale.

Effect size
Mixed; some trials show muscle pain reduction, others show no benefit
Time to effect
Weeks
Best fit
Statin users with documented muscle pain and no other explanation, with confirmed low plasma CoQ10
Less likely
Statin users without muscle symptoms — no preventive benefit shown

Bottom line: Mechanistically plausible for statin myalgia but RCT evidence is inconsistent; worth a supervised trial.

Evidence is mixed

Multiple RCTs show conflicting results — some positive for pain reduction, others null. Meta-analyses have not resolved the question definitively.

blood pressure (biomarker)

Biomarker support
Limited Evidence

Meta-analyses of small RCTs report modest systolic blood pressure reduction (~35 mmHg) with CoQ10 supplementation. Effect size is small and inconsistent across trials. This is a biomarker endpoint; no trial has demonstrated reduction in hypertension-related clinical events. If combined with antihypertensive medications, blood pressure should be monitored.

Effect size
~3–5 mmHg systolic reduction in meta-analyses
Time to effect
Weeks to months
Best fit
Adults with hypertension on antihypertensive therapy

Bottom line: Small blood pressure reduction at the biomarker level — not a substitute for antihypertensive therapy.

How it works

CoQ10's central job is in the electron transport chain inside mitochondria, the cellular machinery that produces ATP, the energy currency of cells. CoQ10 ferries electrons between Complex I or II and Complex III, an essential step in oxidative phosphorylation. Without CoQ10, ATP production collapses. CoQ10 also serves as a potent lipid-phase antioxidant, protecting cell membranes and circulating lipoproteins from oxidative damage. The body's ability to synthesize CoQ10 declines with age, beginning around the third or fourth decade of life, and certain medications interfere with its production. Statins inhibit the enzyme HMG-CoA reductase, which is upstream of both cholesterol and CoQ10 synthesis; consistent reductions in plasma CoQ10 are documented in statin users, and this has been hypothesized as a mechanism for statin-related muscle complaints. CoQ10 supplementation may modestly help statin-induced myalgia in some users, though trial evidence is mixed.

How to take it

1. Typical dose
100–300 mg/day
2. Higher studied dose
300–600 mg/day for migraine prevention and mitochondrial disease
3. Timing
Morning and evening with fat-containing meals
4. With food
Must be taken with fat — absorption is poor on an empty stomach or with a fat-free meal
5. Split dosing
Split into 2 doses (e.g., 100–150 mg twice daily) for steadier plasma levels
6. How long to try
Trial at least 8–12 weeks before assessing effect; heart failure and migraine benefits build over time

What to track

Muscle pain or weakness (statin users)
Exercise tolerance or symptom burden (heart failure)
Migraine frequency and severity
INR if on warfarin
Blood pressure if on antihypertensives

4 commercial forms

Compare the main delivery options and what they’re best suited for.

Ubiquinone (oxidized form)

The most common and economical CoQ10 form. Well-studied and reliable when taken with food.

Standard supplemental form; effective at typical doses with fat.

Ubiquinol (reduced form)

Preferred in adults over 60 or those with documented absorption issues. More expensive.

More readily absorbed in some adults, especially older adults; 2 to 8 times higher plasma CoQ10 levels.

Solubilized or oil-based CoQ10

Various formulations (Q-Gel, Q-Sorb, MicroActive) designed to improve uptake. May allow lower doses for equivalent effect.

Improved absorption through fat-soluble matrices.

CoQ10 powder or dry tablets

Less reliable unless taken with substantial fat-containing meal. Soft gels are generally preferred.

Poor absorption without dietary fat; least effective format.

Safety

Know the common side effects, key cautions, and who should avoid it.

Common side effects

GI upset (nausea, diarrhea)HeartburnHeadacheMild insomnia (take earlier in day if noticed)

Who should avoid it

  • People on warfarin without INR monitoring
  • People undergoing chemotherapy with anthracyclines without oncology coordination

Pregnancy & breastfeeding

Limited data at supplemental doses; generally considered low-risk but high-dose supplementation in pregnancy has not been well-studied — consult a clinician.

Interactions

warfarinModerate

CoQ10 has structural similarity to vitamin K and may reduce anticoagulant effectiveness; monitor INR

anthracycline chemotherapy (doxorubicin, etc.)Moderate

Antioxidant effect may theoretically reduce chemotherapy efficacy; coordinate with oncology

antihypertensivesMinor

Additive blood pressure lowering possible; monitor blood pressure

Documented interactions

Evidence-graded pair pages with sources, dosing notes, and timing guidance — a complement to the narrative section above.

Warnings (5)

+ simvastatin

moderate

Simvastatin blocks HMG-CoA reductase, the enzyme upstream of both cholesterol and coenzyme Q10 (CoQ10) synthesis, so it lowers circulating CoQ10 alongside cholesterol. This depletion is a plausible contributor to statin-associated muscle symptoms, and some randomized trials suggest CoQ10 supplements modestly ease those symptoms — though the evidence is mixed.

+ grapefruit

low

Grapefruit may modestly increase CoQ10 absorption in laboratory studies. The pairing is harmless, but grapefruit can be a serious problem if you also take a grapefruit-sensitive prescription drug.

+ rosuvastatin

low

Rosuvastatin blocks HMG-CoA reductase, the enzyme that makes both cholesterol and coenzyme Q10, so it modestly lowers circulating CoQ10. The depletion is generally smaller than with fat-soluble statins, and mitochondrial impairment is only one proposed mechanism for statin-associated muscle symptoms. This is a possible-benefit pairing, not a dangerous one.

+ metoprolol

low

Metoprolol and other beta-blockers have been shown in laboratory studies to inhibit some CoQ10-dependent enzymes, and long-term beta-blocker therapy is associated with modestly lower CoQ10 levels. There is no absorption clash: CoQ10 does not change metoprolol's blood-pressure or heart-rate effects, and metoprolol does not change how the body uses CoQ10. Whether this depletion meaningfully causes fatigue, or whether CoQ10 supplementation relieves it, rests largely on mechanism rather than interaction-specific trials.

Beneficial pairs (5)

+ red yeast rice

synergy

Red yeast rice's active constituent monacolin K is chemically identical to the statin lovastatin and inhibits HMG-CoA reductase, the shared enzyme step upstream of both cholesterol and coenzyme Q10 (ubiquinone). Statin therapy measurably lowers circulating CoQ10, and CoQ10 depletion is one proposed contributor to statin-type muscle symptoms. Co-taking a CoQ10 supplement replenishes that pool and may help ease statin-type muscle complaints without reducing red yeast rice's cholesterol-lowering effect. This is a complementary, potentially beneficial pairing rather than a harmful conflict.

+ pqq

synergy

CoQ10 carries electrons in the mitochondrial electron transport chain to help produce ATP, while PQQ signals the cell to build new mitochondria via PGC-1alpha. Used together they support both the efficiency and the number of energy-producing mitochondria. The combination is well tolerated, with modest human evidence for cognitive and fatigue benefits.

+ niacin

synergy

Niacin (vitamin B3) is the precursor to NAD+ and NADH, the electron carriers that feed Complex I of the mitochondrial electron transport chain, where CoQ10 shuttles those electrons onward toward ATP synthesis. They support adjacent steps of the same energy-producing pathway, making them a plausible mitochondrial-support pairing. The combination has not been tested head-to-head in humans, so the benefit is biologically reasonable rather than proven.

+ hawthorn

synergy

Hawthorn (Crataegus) flavonoids and oligomeric procyanidins act on the mechanical and vascular side of heart function, while CoQ10 supports the heart's energy metabolism in the electron transport chain. The two are sometimes combined as low-risk cardiovascular adjuncts, but the supportive human evidence is for each ingredient separately, not for the pair, so any "synergy" is extrapolated rather than demonstrated.

See all 10 CoQ10 interactions

Protocols featuring CoQ10

Evidence-backed routines where CoQ10 plays a role.

Statin Companion

medication

Statins are the most-evidenced cardiovascular medication ever invented — they prevent heart attacks, strokes, and cardiovascular death across multiple massive trials. They''re also the most widely-prescribed class of medication in adults over 40. The catch: statins inhibit HMG-CoA reductase, the enzyme that produces cholesterol — but the SAME pathway also produces CoQ10 and dolichols. As a result, statin users show 19-54% reductions in serum CoQ10 in trials, and CoQ10 depletion is implicated in statin-associated muscle symptoms (the most common reason patients discontinue statins). Vitamin D status independently affects statin tolerance. Omega-3 complements statin lipid management. This protocol is for adults ACTIVELY on a statin medication (atorvastatin/Lipitor, rosuvastatin/Crestor, simvastatin/Zocor, pravastatin, etc.). The goal: mitigate side effects, support muscle and energy, complement cardiovascular protection. CRITICAL: this protocol does NOT replace your statin. Statins prevent cardiovascular events; the supplements address downstream effects. If you''re experiencing statin-related muscle symptoms, talk to your cardiologist or PCP. Options include CoQ10 supplementation, switching statin type, lowering dose, alternative-day dosing, or in rare cases switching medication class entirely. Don''t stop your statin without medical guidance.

Metformin Companion

medication

Metformin is the most-prescribed type 2 diabetes medication and is increasingly used off-label for prediabetes, PCOS, and even longevity research. The catch: long-term metformin use is associated with vitamin B12 deficiency in 5-30% of users — the exact mechanism involves reduced B12 absorption in the small intestine. B12 deficiency on metformin develops slowly (typically 4+ years of use) and produces fatigue, cognitive symptoms, and peripheral neuropathy — symptoms commonly misattributed to diabetes itself. Metformin also modestly affects folate and CoQ10, and magnesium supplementation may enhance metformin''s metabolic effects. This protocol is for adults ACTIVELY on metformin (any indication: T2DM, prediabetes, PCOS, or off-label use). CRITICAL: this protocol does NOT replace metformin. The supplements address downstream nutritional effects. The American Diabetes Association recommends periodic B12 testing for long-term metformin users — particularly in adults over 50, vegetarians/vegans, and those with neurological symptoms. Don''t skip B12 monitoring.

Men's Essentials 30-50

general

The decade between 30 and 50 is when men start to drift from "automatic health" into actively maintained health. Testosterone declines ~1% per year starting around 30, cardiovascular risk markers begin shifting, lean muscle mass starts to decrease without active training, and small recovery imbalances accumulate. This protocol is the everyday foundation specifically calibrated for men in this window: vitamin D, magnesium, omega-3, zinc, and CoQ10. Each addresses a relevant pathway — testosterone synthesis, cardiovascular protection, sleep and stress, mitochondrial energy. Layer goal-specific protocols (Testosterone Support, Foundational Longevity, Joint Health) on top of this baseline as needed.

Birth Control Companion

medication

Combined oral contraceptives (estrogen + progestin) are one of the most-prescribed medications globally, with hundreds of millions of users. Long-term use is documented to deplete several nutrients: B6, B12, folate, magnesium, zinc, CoQ10, and vitamin C — with the depletion mechanism varying by nutrient (some via altered absorption, others via increased turnover). The clinical relevance: depleted B vitamins are implicated in oral contraceptive-related mood changes, fatigue, headaches, and elevated homocysteine. Magnesium depletion may contribute to migraines and PMS-like symptoms common in pill users. This protocol is for women ACTIVELY on combined oral contraceptives, progestin-only pills, or other hormonal contraceptives (patch, ring, implant, IUD with hormone, injection). It''s NOT for non-hormonal IUDs (copper) or barrier methods. CRITICAL: this protocol does NOT advise stopping contraception. It supports nutritional status while you''re on hormonal birth control. If you''re experiencing mood changes, fatigue, headaches, or other side effects you suspect are pill-related, this stack may help — but also consider discussing alternative formulations or methods with your prescriber. Different pills affect different women differently.

Brain Fog Recovery

focus

"Brain fog" — difficulty concentrating, slow word retrieval, sluggish thinking, mental fatigue — exploded as a search term post-2020 with Long COVID and persistent post-viral cognitive symptoms. It''s also common in perimenopause, chronic stress, ADHD, post-COVID recovery, fibromyalgia, ME/CFS, and after periods of severe sleep deprivation. The underlying mechanisms typically involve some combination of neuroinflammation, mitochondrial dysfunction, neurotransmitter dysregulation, and disrupted cerebral blood flow. This stack targets these pathways: lion''s mane for nerve growth factor support, citicoline for acetylcholine and membrane phospholipid synthesis, B12 for methylation and neurological function, omega-3 DHA for neuronal membrane structure, and CoQ10 for mitochondrial energy in neurons. If your brain fog is severe, sudden, or follows a specific trigger (infection, head injury, new medication), see your doctor — workup matters. Long COVID specifically has emerging treatment protocols; you don''t have to white-knuckle it.

Cholesterol Support

cardiovascular

Elevated LDL-C and ApoB are causal drivers of cardiovascular disease — the leading killer of adults. Statins are the gold-standard pharmaceutical intervention with the strongest trial evidence ever assembled in medicine. This stack is NOT a substitute for statin therapy when one is indicated by your cardiovascular risk profile. It IS useful as: a complement to statins for additional LDL reduction, an option for statin-intolerant adults, or a preventive layer for adults with borderline lipids who want to reduce risk before pharmaceutical intervention is warranted. Red yeast rice is essentially low-dose lovastatin (a natural statin compound) and carries similar precautions; bergamot, plant sterols, and niacin each have independent LDL-lowering evidence with different mechanisms. If your LDL-C is over 160 mg/dL, you have a family history of premature cardiovascular disease, or you have other risk factors, please see your doctor. ApoB is a better predictor than LDL-C alone; ask for it.

Heart Health Foundation

cardiovascular

Cardiovascular disease is the leading killer of adults globally. The supplement category for heart health is overrun with marketing, but a handful of compounds have legitimate long-term human evidence: omega-3 EPA/DHA, CoQ10, magnesium, vitamin K2, and taurine. None of these replace evidence-based pharmaceutical therapy (statins, ACE inhibitors, etc.) when one is medically indicated. They DO function well as a preventive baseline for adults without active cardiovascular disease, and as complements to medical therapy. This protocol is for cardiovascular maintenance and primary prevention — see Cholesterol Support or Blood Pressure Support for goal-specific protocols.

Morning Energy & Drive

energy

Morning fatigue and low drive — distinct from afternoon crashes (see Afternoon Energy) and chronic fatigue (see Chronic Fatigue Recovery) — is usually a circadian/HPA-axis pattern. Healthy adults experience a cortisol awakening response (CAR) in the first 30-45 minutes after waking; flattened or blunted CAR produces the "wake up still tired" feeling. The drivers are usually insufficient sleep duration, fragmented sleep architecture, vitamin and mineral gaps (especially B-complex and iron in women), thyroid issues, or chronic HPA-axis dysregulation. This stack supports the energy-production pathways: B-complex for cellular ATP production, L-tyrosine for dopamine/norepinephrine synthesis, rhodiola for stress-related fatigue, and CoQ10 for mitochondrial function. If you''re consistently exhausted on adequate sleep, get labs first: ferritin, TSH and free T4, fasting glucose, B12, 25-OH vitamin D. Many "I''m just tired" complaints have a reversible underlying cause.

Diuretic / Blood Pressure Med Companion

medication

Diuretics are first-line blood pressure medications and a cornerstone of heart failure management. Loop diuretics (furosemide/Lasix, bumetanide, torsemide) and thiazides (hydrochlorothiazide/HCTZ, chlorthalidone, indapamide) work by increasing urinary excretion of sodium and water — but they also flush out magnesium, potassium, zinc, and (less appreciated) thiamine alongside. The depletion is dose- and duration-dependent: roughly 20-30% of long-term diuretic users develop measurable hypomagnesemia, and a meaningful fraction also show low-normal potassium that the standard panel misses. This protocol is for adults ACTIVELY on a loop or thiazide diuretic for hypertension, edema, or heart failure. The goal is narrow: replace the nutrients your medication is documented to deplete, and add cardiovascular cofactors with reasonable evidence. The supplements address downstream nutrient losses — they don't replace your medication and they don't treat your underlying condition. CRITICAL distinction: potassium-SPARING diuretics (spironolactone/Aldactone, eplerenone/Inspra, triamterene, amiloride, and combinations like HCTZ-triamterene/Dyazide) do the opposite — they retain potassium. Potassium supplementation while on these drugs can cause life-threatening hyperkalemia. You must know which class your diuretic is in before starting any potassium supplement. If you're unsure, ask your pharmacist or prescriber.

Blood Pressure Support

cardiovascular

High blood pressure is one of the most common adult conditions and one of the most under-treated. The supplement category for blood pressure has reasonable evidence for a handful of compounds — magnesium, hibiscus tea, beetroot (nitrates), CoQ10, and potassium-rich foods. None of these replace antihypertensive medication when one is medically indicated. They CAN be useful for adults with borderline or stage-1 hypertension who want a lifestyle-first approach, as complements to medications for additional reduction, or as preventive layers. Lifestyle (DASH diet, sodium-potassium balance, weight loss, exercise) does the heaviest lifting; supplements are a secondary layer. If your resting blood pressure is consistently above 140/90, please see your doctor. Untreated hypertension is one of the largest preventable contributors to stroke, kidney disease, and cardiovascular events.

Food sources

Beef heart (3 oz)

Amount
~33 mg
%DV

Sardines (3 oz)

Amount
~6 mg
%DV

Mackerel (3 oz)

Amount
~3 to 7 mg
%DV

Beef (3 oz)

Amount
~2 to 4 mg
%DV

Chicken (3 oz)

Amount
~1 mg
%DV

Pistachios (1 oz)

Amount
~6 mg
%DV

Spinach (1 cup raw)

Amount
~1 mg
%DV

Choosing a product

What to look for on the label — and what to be skeptical of.

Look for

Ubiquinol (reduced form) for people over 40 or with malabsorption — higher bioavailability than ubiquinone
Dose stated in mg with form specified
Fat-soluble — look for softgel or oil-based formulation
Third-party tested for potency

Be skeptical of

'Reverses aging'
'Treats heart disease'
'Proven to cure statin myopathy'
'Anti-aging miracle'

Frequently asked questions

Should I take ubiquinone or ubiquinol?

For most adults under 60 with normal absorption, ubiquinone (the oxidized form) at 100 to 200 mg/day with food works fine and costs less. For adults over 60, those with chronic conditions affecting absorption, or those who don't respond to ubiquinone, ubiquinol (reduced form) is more readily absorbed and may be worth the extra cost.

Do statins really deplete CoQ10?

Yes, plasma CoQ10 is consistently lower in statin users. Whether this depletion causes the muscle symptoms some patients experience is debated. Trials of CoQ10 for statin-induced myalgia show mixed results. Many cardiologists support a trial of 100 to 200 mg/day for patients with statin muscle complaints.

Will CoQ10 help my energy levels?

If you have a documented CoQ10 deficiency, mitochondrial disorder, or take statins, supplementation may improve energy. In healthy adults with normal CoQ10 status, subjective energy effects are usually subtle. Don't expect a stimulant-like boost.

Is CoQ10 safe to take long-term?

Yes. Trials have used CoQ10 for years at 100 to 300 mg/day with excellent safety. Even higher doses (up to 3,000 mg/day) have been used in mitochondrial disease research without major signals.

Can I take CoQ10 with my blood pressure medication?

Yes, but monitor your readings. CoQ10 modestly lowers blood pressure, which can compound with antihypertensives. Your prescriber may need to adjust doses over time.

References by claim

heart failure (adjunctive support)

Xu et al., 2024PMC (2024) link

Al et al., 2021PMC (2021) link

migraine prevention

Sazali et al., 2021PMC (2021) link

Parohan et al., 2020PubMed (2020) link

statin-induced myalgia

Wei et al., 2022PubMed (2022) link

Banach et al., 2015PubMed (2015) link

blood pressure (biomarker)

Zhao et al., 2022PMC (2022) link

Tabrizi et al., 2018PubMed (2018) link

Track CoQ10 with Pilora

Set up dose reminders, check interactions, and join the community in the Pilora iPhone app.

Coming to App Store
Evidence-based·Last reviewed May 30, 2026·Evidence current as of May 30, 2026·How we grade evidence

Disclaimer: These statements have not been evaluated by the FDA. This page is educational, not a substitute for personalized medical advice. Evidence grades are AI-assisted assessments — talk to your doctor before starting any new supplement, especially if you’re pregnant, breastfeeding, on medications, or managing a chronic condition.